Hamlin Capital Management LLC Sells 8,030 Shares of Procter & Gamble Company (The) $PG

Hamlin Capital Management LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 0.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,059,367 shares of the company’s stock after selling 8,030 shares during the quarter. Procter & Gamble accounts for approximately 3.5% of Hamlin Capital Management LLC’s holdings, making the stock its 15th biggest holding. Hamlin Capital Management LLC’s holdings in Procter & Gamble were worth $155,346,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Brighton Jones LLC lifted its holdings in shares of Procter & Gamble by 51.5% during the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after acquiring an additional 13,617 shares during the period. Taylor Financial Group Inc. boosted its position in Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after buying an additional 277 shares in the last quarter. Sivia Capital Partners LLC boosted its position in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after buying an additional 1,016 shares in the last quarter. Auxano Advisors LLC grew its stake in Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after buying an additional 714 shares during the last quarter. Finally, Schnieders Capital Management LLC. grew its stake in Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after buying an additional 809 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G agreed to acquire premium supplements company Thorne for $3.8 billion in cash. The transaction expands P&G’s health-care portfolio alongside brands such as Metamucil, Align and New Chapter, and gives the company greater exposure to premium wellness and younger consumers. The deal is expected to close later this year. P&G will acquire supplements brand Thorne
• Positive Sentiment: Management and Thorne’s owner described the acquisition as a way to build on Thorne’s science-backed brand and growth in wellness. Investors initially viewed the purchase as a strategic move to diversify P&G beyond traditional household and personal-care products. L Catterton announces sale of Thorne to P&G
• Neutral Sentiment: Trading activity in P&G call options increased, indicating heightened investor interest and potentially more bullish positioning around the acquisition. However, options activity alone does not establish a change in the company’s fundamentals. Traders purchase large volume of P&G call options
• Negative Sentiment: P&G’s latest quarterly results showed a mixed picture: earnings per share of $1.43 topped estimates by $0.02, but revenue of $21.2 billion missed the $21.38 billion consensus and rose only 1.5% year over year. The sales shortfall and ongoing input-cost pressure may be limiting enthusiasm for the stock. PG Q2 deep dive
• Negative Sentiment: The $3.8 billion cash purchase creates execution and valuation risk, including the challenge of integrating Thorne and generating sufficient growth from the premium supplement business. Investors may also be assessing the deal’s effect on P&G’s balance sheet and future returns.

Procter & Gamble Price Performance

PG opened at $146.79 on Thursday. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.68 and a quick ratio of 0.47. The stock has a market capitalization of $341.81 billion, a P/E ratio of 22.17, a price-to-earnings-growth ratio of 4.55 and a beta of 0.39. The company’s 50 day simple moving average is $147.80 and its 200-day simple moving average is $148.99. Procter & Gamble Company has a one year low of $137.62 and a one year high of $167.25.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.25%. The firm had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same quarter in the previous year, the company posted $1.48 EPS. Procter & Gamble’s revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Sell-side analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is presently 65.71%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on PG shares. Citigroup cut their target price on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $163.00 price target on shares of Procter & Gamble in a report on Monday, April 27th. UBS Group lifted their price objective on Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a report on Wednesday, June 24th. Finally, Jefferies Financial Group raised their target price on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.52.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.